Title: HOUSE BILL NO. 1543
Official Title: HOUSE BILL NO. 1543
Number of Sections: 1
Source: versions - INTRODUCED
Media Type: application/pdf
Strikethrough Detection: 1 sections found

================================================================================

Section 1:
25.1305.01000
Sixty-ninth
Legislative Assembly
of North Dakota
Introduced by
Representatives Meier, K. Anderson, Bolinske, Dobervich, Frelich, Heinert, Holle, Rohr,
Weisz
Senators Cleary, Dever, Hogan
1 A BILL for an Act to provide for a legislative management study regarding prescription drug
2 pricing and the maximum fair price as determined by the federal government.
3 BE IT ENACTED BY THE LEGISLATIVE ASSEMBLY OF NORTH DAKOTA:
4 SECTION 1. LEGISLATIVE MANAGEMENT STUDY - PRESCRIPTION DRUG PRICING.
5 1. During the 2025-26 interim, the legislative management shall consider studying
6 prescription drug pricing or the maximum fair price for a drug as published by the
7 secretary of the United States department of health and human services.
8 2. The study must include consideration of federal drug price negotiations under the
9 Federal Inflation Reduction Act of 2022 [Pub. L. 117-169; 26 U.S.C. 55 et seq.] and
10 overlap with current drugs paid for by the public employees retirement system to
11 determine usage and potential cost-savings to the state and consumers.
12 3. The study must include input from:
13 a. The public employees retirement system;
14 b. The insurance commissioner;
15 c. The state board of pharmacy; and
16 d. Other stakeholders.
17 4. The legislative management shall report its findings and recommendations, together
18 with any legislation necessary to implement the recommendations, to the seventieth
19 legislative assembly.
Page No. 1 25.1305.01000
[DELETED: .D.T.T.T.T.T.O.T12]


================================================================================

Raw Text:
25.1305.01000
Sixty-ninth
HOUSE BILL NO. 1543
Legislative Assembly
of North Dakota
Introduced by
Representatives Meier, K. Anderson, Bolinske, Dobervich, Frelich, Heinert, Holle, Rohr,
Weisz
Senators Cleary, Dever, Hogan
1 A BILL for an Act to provide for a legislative management study regarding prescription drug
2 pricing and the maximum fair price as determined by the federal government.
3 BE IT ENACTED BY THE LEGISLATIVE ASSEMBLY OF NORTH DAKOTA:
4 SECTION 1. LEGISLATIVE MANAGEMENT STUDY - PRESCRIPTION DRUG PRICING.
5 1. During the 2025-26 interim, the legislative management shall consider studying
6 prescription drug pricing or the maximum fair price for a drug as published by the
7 secretary of the United States department of health and human services.
8 2. The study must include consideration of federal drug price negotiations under the
9 Federal Inflation Reduction Act of 2022 [Pub. L. 117-169; 26 U.S.C. 55 et seq.] and
10 overlap with current drugs paid for by the public employees retirement system to
11 determine usage and potential cost-savings to the state and consumers.
12 3. The study must include input from:
13 a. The public employees retirement system;
14 b. The insurance commissioner;
15 c. The state board of pharmacy; and
16 d. Other stakeholders.
17 4. The legislative management shall report its findings and recommendations, together
18 with any legislation necessary to implement the recommendations, to the seventieth
19 legislative assembly.
Page No. 1 25.1305.01000

[DELETED: .D.T.T.T.T.T.O.T12]